Futu Information on August 8 | the three major indexes of Hong Kong stocks fell collectively, with the Hang Seng Index down 0.75%, the Hang Seng Index down 1.69%, and the State-owned Enterprises Index down 1.09%.
By midday's close, Hong Kong stocks were up 621, down 930, to close flat at 1346.
The specific industry performance is shown below:
Tuyuan Futu Niuniu APP- Market-opportunity-Heat Map
Plate aspectLarge-scale technology stocks generally fellBABA fell nearly 4%, JD.com and Kuaishou Technology fell about 3%, and Tencent and Meituan fell more than 2%.
Coal stocks are strongYanzhou Mining Energy rose by more than 4%, China Coal Energy by more than 2% and China Shenhua Energy by more than 1%. Coal rose in Australia.
Differentiation of the trend of medical stocksINNOVENT BIO is up nearly 6%, Pharmaron Beijing Co., Ltd.* is down nearly 6%, and Wuxi Apptec is down more than 1%.
The semiconductor plate rises and falls differently.Hongguang Semiconductor rose more than 24% and ASM Pacific rose nearly 1%, while Semiconductor Manufacturing International Corporation and Hua Hong Semiconductor fell about 2%.
Auto stocks weakenXPeng Inc. fell nearly 3%, Geely Automobile and Great Wall Motor fell nearly 2%.
Sporting goods stocks fellLi Ning Co. Ltd. fell by more than 3%, Anta and Xtep by more than 2%.
Education stocks are lower.New Oriental Education & Technology Group online fell more than 7%, New Oriental Education & Technology Group-S and Tianli International Holdings fell nearly 4%, and Yuhua Education fell more than 3%.
Individual stocks$BABA-SW (09988.HK) $Down nearly 4%.Macquarie released a research report that reaffirmed BABA-SW's "outperform" rating and raised its adjusted diluted earnings per share forecast for fiscal year 2023 from HK $145 to HK $148.
$INNOVENT BIO (01801.HK) $Up nearly 6%.In the news, INNOVENT BIO recently announced that he has reached a multi-project strategic cooperation with Sanofi Group to carry out the clinical development and commercialization of two high-potential antineoplastic drugs SAR408701 and SAR444245 in China. In addition, UBS issued a report to lower INNOVENT BIO's Tyvyt sales forecast for this year, but raised the target price from 39.3 yuan to 42 yuan, with a rating of "buy", taking into account Sanofi's investment.
$Yanzhou Mining Energy (01171.HK) $It's up more than 4%.On the news, the International Energy Agency (IEA) predicted in July that EU coal consumption would grow by 7 per cent in 2022 from 14 per cent last year, and global coal consumption would rise 0.7 per cent to 8 billion tonnes from a year earlier, close to the all-time high set in 2013. The agency also expects global coal demand to increase further in 2023.
$Cosco Haineng (01138.HK) $It's up more than 6%.On the news side, the MR of oil products has fallen by 1% in the last week. Shen Wanhong source pointed out that the off-season is not off-season and the peak season is expected, and there is a significant marginal improvement in VLCC market demand, and continue to recommend COSCO Haineng and other oil transportation companies.
$minimally invasive medical treatment (00853.HK) $It fell by nearly 7%.On the news side, minimally invasive Medical announced that the group's sales revenue maintained steady growth in the first half of 2022; the group is expected to make a loss of about $193 million to $203 million during the period attributable to the company's equity shareholders. the loss during the same period last year was about $90.3 million.
Half-day turnover TOP20
Edit / ruby